Cargando…

Corrigendum: Magnetization Transfer Ratio in Lower Limbs of Late Onset Pompe Patients Correlates With Intramuscular Fat Fraction and Muscle Function Tests

Detalles Bibliográficos
Autores principales:	Nuñez-Peralta, Claudia, Montesinos, Paula, Alonso-Jiménez, Alicia, Alonso-Pérez, Jorge, Reyes-Leiva, David, Sánchez-González, Javier, Llauger-Roselló, Jaume, Segovia, Sonia, Belmonte, Izaskun, Pedrosa, Irene, Martínez-Noguera, Antonio, Matellini-Mosca, Briano, Walter, Glenn, Díaz-Manera, Jordi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315134/ https://www.ncbi.nlm.nih.gov/pubmed/34326809 http://dx.doi.org/10.3389/fneur.2021.727020

Ejemplares similares

Magnetization Transfer Ratio in Lower Limbs of Late Onset Pompe Patients Correlates With Intramuscular Fat Fraction and Muscle Function Tests
por: Nuñez-Peralta, Claudia, et al.
Publicado: (2021)

Different Approaches to Analyze Muscle Fat Replacement With Dixon MRI in Pompe Disease
por: Alonso-Jiménez, Alicia, et al.
Publicado: (2021)

Correlation Between Respiratory Accessory Muscles and Diaphragm Pillars MRI and Pulmonary Function Test in Late-Onset Pompe Disease Patients
por: Reyes-Leiva, David, et al.
Publicado: (2021)

Follow‐up of late‐onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles
por: Nuñez‐Peralta, Claudia, et al.
Publicado: (2020)

Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study
por: Figueroa-Bonaparte, Sebastian, et al.
Publicado: (2018)

PDGF-BB serum levels are decreased in adult onset Pompe patients
por: Fernández-Simón, Esther, et al.
Publicado: (2019)

Muscle MRI Findings in Childhood/Adult Onset Pompe Disease Correlate with Muscle Function
por: Figueroa-Bonaparte, Sebastián, et al.
Publicado: (2016)

Identification of serum microRNAs as potential biomarkers in Pompe disease
por: Carrasco‐Rozas, Ana, et al.
Publicado: (2019)

MON-LB073 The Serum Creatinine to Serum Cystatin C Ratio Is a Reliable Surrogate Marker of Sarcopenia in Patients with Cushing's Syndrome in Remission
por: Martel, Luciana, et al.
Publicado: (2019)

Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies
por: Alonso-Jiménez, Alicia, et al.
Publicado: (2021)

MON-LB074 Ultrasonography May Reliably Assess Muscle Architecture in Patients with Cushing's Syndrome in Remission: Comparison with Gold-Standard Muscle MRI
por: Martel, Luciana, et al.
Publicado: (2019)

Muscle MRI in muscular dystrophies
por: Díaz-Manera, Jordi, et al.
Publicado: (2015)

Therapeutic Options for the Management of Pompe Disease: Current Challenges and Clinical Evidence in Therapeutics and Clinical Risk Management
por: Bolano-Diaz, Carla, et al.
Publicado: (2022)

Survey on the management of Pompe disease in routine clinical practice in Spain
por: Domínguez-González, Cristina, et al.
Publicado: (2022)

STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa
por: Gutschmidt, Kristina, et al.
Publicado: (2021)

Diffuse Intramuscular Lipomatosis of a Lower Limb
por: Morris, Alfred D., et al.
Publicado: (1998)

A misplaced intramuscular injection and limb-threatening ischemia
por: Sarkar, Sumantra, et al.
Publicado: (2017)

Pompes turbomoleculaires
por: Versolatto, B
Publicado: (1982)

Characteristics of Pompe disease in China: a report from the Pompe registry
por: Zhao, Yuying, et al.
Publicado: (2019)

Neurofilament Light and Its Association With CNS Involvement in Patients With Classic Infantile Pompe Disease
por: Mackenbach, Maarten J., et al.
Publicado: (2023)

Raccords de pompes
por: Riboni, P
Publicado: (1976)

Pregnancy in Pompe disease
por: Plöckinger, Ursula
Publicado: (2013)

Familial Pompe Disease
por: Tecellioglu, Mehmet, et al.
Publicado: (2015)

The Pompe Registry: tracking Pompe disease symptoms in a broad patient population
por: Byrne, B, et al.
Publicado: (2008)

Comprehensive functional characterization of SGCB coding variants predicts pathogenicity in limb-girdle muscular dystrophy type R4/2E
por: Li, Chengcheng, et al.
Publicado: (2023)

Increased Adsorption of Heavy Metal Ions in Multi-Walled Carbon Nanotubes with Improved Dispersion Stability
por: Rodríguez, Carolina, et al.
Publicado: (2020)

Effects of Folinic Acid Administration on Lower Limb Ischemia/Reperfusion Injury in Rats
por: Cearra, Iñigo, et al.
Publicado: (2021)

Quantification of intramuscular fat in patients with late-onset Pompe disease by conventional magnetic resonance imaging for the long-term follow-up of enzyme replacement therapy
por: Lollert, André, et al.
Publicado: (2018)

Hydrostatic Isolated Limb Perfusion with Adeno-associated Virus Vectors Enhances Correction of Skeletal Muscle in Pompe Disease
por: Sun, Baodong, et al.
Publicado: (2010)

Genetic counseling in Pompe disease
por: Taglia, Antonella, et al.
Publicado: (2011)

Hearing in adults with Pompe disease
por: van der Beek, Nadine A. M. E., et al.
Publicado: (2011)

Les pompes à chaleur
por: Veith, Heinz, et al.
Publicado: (1974)

Les pompes à chaleur
por: Dumon, Roger, et al.
Publicado: (1980)

Pompe 3500 1/s MSC
por: Versolatto, B
Publicado: (1978)

Pompe disease: the role of MRI
por: Fernández, C Pérez, et al.
Publicado: (2013)

Clinical features of Pompe disease
por: MANGANELLI, FIORE, et al.
Publicado: (2013)

Newborn Screening for Pompe Disease
por: Sawada, Takaaki, et al.
Publicado: (2020)

The Prevention of Ischemia-Reperfusion Injury in Elderly Rats after Lower Limb Tourniquet Use
por: Herrero de la Parte, Borja, et al.
Publicado: (2022)

Upper limb gangrene following intramuscular diclofenac: a rare side effect
por: Hajong, Ranendra
Publicado: (2013)

Pulmonary rehabilitation restores limb muscle mitochondria and improves the intramuscular metabolic profile
por: Qumu, Shiwei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mu5vnk8n5lef9m8hg8h8c3losn